Clinical Trials Directory

Trials / Unknown

UnknownNCT03488888

PEC Block II in Mammoplasty Surgeries

Evaluation of Pectoral Nerve Blocks II for Augmentation Mammoplasty Surgeries. Prospective, Randomized, Double-blind Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Federal University of São Paulo · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Breast augmentation surgery is the top cosmetic surgery in USA with more then 300.000 cases performed annually. Pain is a common complications of the procedure accompanied of dyspnea and nausea due to the surgical manipulation. Several anesthetic techniques were developed with the objective of providing optimal surgical conditions together with enhanced recovery and post-op pain management. Pectoralis major block was first described in 2011 by Blanco in female patients undergoing oncologic procedures in the anterior thoracic wall. The investigators hypothesized if the Pectoralis Major block combined with general anesthesia standard techniques could be beneficial in improving pain scores and opioid consumption during post operative period of patients undergoing breast augmentation surgery.

Detailed description

Patients undergoing Breast Augmentation Mammoplasty were submitted to laryngeal mask placement after anesthetic induction with Fentanyl 3ucg/kg , Propofol 2mg/kg and Atracurium 0,5mg/kg and surgery was performed under standard surgical practices. Before the surgical incision patients were randomized either to receive a Bilateral Pectoralis Major Block(PEC I and II) with Bupivacaine 0,25% with Epinephrine or to receive a placebo block with Normal Saline 0,9%. After the procedure all patients received a intravenous patient-controlled-analgesia pump device with morphine. Pain and opioid consumption were assessed with a pain score assessment tool and assessment of the pump administration dosage history. No NSAIDs or alpha 2 agonist drugs were administered during or after the procedure. The maintenance of anesthesia was performed with Propofol and Remifentanil Total intravenous anesthesia(TIVA) models in a standardized fashion. Micromanagement of anesthetic drugs was performed by the assistant anesthesiologist physician.

Conditions

Interventions

TypeNameDescription
DRUGNormal Saline 0,9%Ultrasound-guided PEC II block with 30 mL of Normal Saline 0,9%
DRUGBupivacaineUltrasound-Guided PEC block with 30 mL of 0.25% bupivacaine solution

Timeline

Start date
2017-11-03
Primary completion
2018-12-01
Completion
2019-01-01
First posted
2018-04-05
Last updated
2018-04-05

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03488888. Inclusion in this directory is not an endorsement.